Page Menu

FILE - In this Jan. 20, 2010 file photo, a subject's waist is measured during an obesity prevention study in Chicago. Obesity rates in the U.S. have been rising steadily for well over a decade and some of the world’s biggest drug developers are tapping into the growing treatment market. Novo Nordisk reported another surge in profits and revenue during its most recent quarter with a big assist from Wegovy, an injectable treatment for weight loss approved by the Food and Drug Administration in 2021. (AP Photo/M. Spencer Green, File)
Studio 2
Weight-loss meds for all?

A Super Bowl ad for compounded versions of the popular brand name weight-loss drugs has caused controversy. Should weight-loss drugs be for everyone?

Weight-loss meds for all?

Archived Programs

A.I. Nation

A.I. Nation

Commonspace

Cosby Unraveled

Eleanor Amplified

Grapple

Half Vaxxed

Half Vaxxed

March On: The Fight for Pride logo

March On: The Fight for Pride

Radio Times

Real Black History

Real Black History

Skytalk with Dave Heller & Dr. Derrick Pitts

Skytalk

The Why

You Bet Your Garden